bristol-myers squibb

Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included the iPhone maker, a top oilfield services stock and a pharmaceutical giant. FAANG stocks, the top cryptocurrency and meme stocks were among the bearish calls seen....

Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included airlines, Chinese EV makers and a consumer electronics giant. An auto giant and a new exchange-traded fund were among the bearish calls that were seen. The quarter...

This weekend's Barron's cover story discusses how the U.S. economy could soar as the pandemic fades. Other featured articles discuss why big pharmaceutical stocks are cheap, the outlook for the aerospace industry and what comes next for three meme stocks. Also, the prospects for an...

Benzinga has examined the prospects for many investor favorite stocks over the past week. This week's bullish calls included e-commerce and pharmaceutical giants. The house that Warren Buffett built is featured among the bearish calls. The Dow Jones industrials and the S&P 500 ended last...

Insider buying can be an encouraging signal for potential investors. Insiders were buying shares last week in the wake of earnings reports. Two big drugmakers saw sizable insider purchases in the past week. Conventional wisdom says that insiders and 10% owners really only buy shares of a company...

Benzinga has examined prospects for many investor favorite stocks over the past week. M&A candidates were among both the bullish and bearish calls last week. Top software stocks also saw both bullish and bearish calls. The big U.S. indexes ended the past week down marginally as investors...

Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included big cloud plays, a leading retailer and a social media giant. Bearish calls included an electric vehicle leader, a struggling industrial giant and a big pharma. The broader equity...

Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included a top retailer, a leading pharmaceutical company and a regional bank. Bearish calls featured an industrial giant, a big biotech and an oilfield services provider. Volatility may have...

Pharmaceutical giants Bristol-Myers Squibb Co (NYSE: BMY) and Merck & Co., Inc. (NYSE: MRK) both release their second quarter earnings reports this week. According to BMO Capital, investors should be buying Merck and selling Bristol-Myers ahead of earnings. Despite Merck being on the verge of...

This weekend's Barron's offers a look at a big pharma stock that acts like a big tech one. Other featured articles discuss an old-school chip stock poised to reward investors and who the players may be in the coming surge in cable and wireless deal making. The prospects for an obscure aircraft...

Pharmaceutical M&A chatter has swirled this month. Short sellers have piled on to one possible buyer. Its share price rose in the first two weeks of February. Rumors that Pfizer Inc. (NYSE: PFE) had its eye on not just one acquisition but possibly two have helped lift the company...

Three leading biotech companies will step into the earnings spotlight this week. Consensus forecasts from Wall Street analysts call for earnings growth from just two of them. And only one of them has topped estimates by double-digits in recent quarters. While the biotechnology industry has had a...

The three largest biotechs are set to share their latest quarterly results this week. Wall Street analysts are looking for solid to strong growth from all three. However, expectations are lower for many other biotech and pharmaceutical companies reporting this week. The three largest public...

The cover story in this weekend's Barron's makes a case that outsider presidential candidates Bernie Sanders and Donald Trump are among pressures on the stock market. Do investors have every right to be nervous about what is playing out on the campaign trail? Other featured articles focus on women...

Featured stories in this weekend's Barron's offer a look at the prospects for a leading pharmaceutical, an overlooked banking bargain and more. A CEO discusses how he plans to take on his company's larger sports apparel rival. Also, check out eight stocks that have dividend staying power. "...